The same visceral fat that drives metabolic disease also converts testosterone to estrogen through an enzyme called aromatase
Not everyone has had the experiences that Ive had, and hopefully 13-year-olds don't
The high performance of the placebo group was somewhat surprising, says Wajahat Mehal, MD, DPhil, a professor of medicine and the director of the Yale fatty liver disease program in New Haven, Connecticut, who was not involved in this study
By activating these receptors, GLP-1 medications increase insulin secretion, reduce blood sugar levels, decrease glucagon release, slow down gastric emptying, and promote satiety, leading to reduced food intake and weight loss
Both drug classes were equally effective in reducing combined major adverse cardiac events such as heart attack, stroke, and death from cardiovascular disease, compared to people with diabetes who were not taking the drugs.[3] The rate of hospitalization for heart failure was 32% less in patients taking SGLT2 inhibitors compared to patients not taking the drugs, especially in those with more severe cardiovascular disease risk
